Global Pathogen Detection Market, By Type (Products, Services), Consistency (Solid Media, Liquid Media), Culture Media (Chemical Composition, Synthetic Media), Contaminant Type (Salmonella, E. Coli, Listeria, Campylobacter, Clostridium Perfringens, Pseudomonas, Cronobacter, Coliforms, Legionella, Others), Total Count (Spoiling Organisms, Yeast and Moulds, Others), Technology (Rapid, Traditional, Other Molecular-Based Tests), Customer Type (Service Lab, Industry, Governmental/Non-Profit Organization), Application (Diagnostics, Pathology, Forensics, Clinical Research, Drug Discovery), End User (Pathology Laboratories, Diagnostic Centers, Hospitals, Biotechnology Companies, Pharmaceutical Companies, Culture Collection Repositories, Cooling Towers, Blood Banks, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Pathogen Detection Market Analysis and Size
Major factors driving the growth of this market are growth in the research and development activities in diagnostic industries have moved forwards and innovation towards rapid detection has led to improvement in the pathogen detection market. Ongoing technology developments and newer applications in R&D have helped to mitigate the impact of pathogen-based infectious disease burden. Additionally, the rapid detection and accuracy in results within less time have further boosted the demand for pathogen detection in coming years.
Data Bridge Market Research analyses that the pathogen detection market which was USD 4.9 billion in 2022, is expected to reach USD 9.07 billion by 2030, at a CAGR of 8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pathogen Detection Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Type (Products, Services), Consistency (Solid Media, Liquid Media), Culture Media (Chemical Composition, Synthetic Media), Contaminant Type (Salmonella, E. Coli, Listeria, Campylobacter, Clostridium Perfringens, Pseudomonas, Cronobacter, Coliforms, Legionella, Others), Total Count (Spoiling Organisms, Yeast and Moulds, Others), Technology (Rapid, Traditional, Other Molecular-Based Tests), Customer Type (Service Lab, Industry, Governmental/Non-Profit Organization), Application (Diagnostics, Pathology, Forensics, Clinical Research, Drug Discovery), End User (Pathology Laboratories, Diagnostic Centers, Hospitals, Biotechnology Companies, Pharmaceutical Companies, Culture Collection Repositories, Cooling Towers, Blood Banks, Others), Distribution Channel (Direct Tender, Retail Sales)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BIOMÉRIEUX (France), Agilent Technologies, Inc. (U.S.), BD (U.S.), biotools (U.S.), SGS Société Générale de Surveillance SA (Switzerland), Bureau Veritas (India) Private Limited (India), Intertek Group plc (U.K.), Eurofins Scientific (Luxembourg), Mérieux NutriSciences Corporation (France), ifp Institut für Produktqualität GmbH (Germany), ALS (Australia), Microbac Laboratories, Inc. (U.S.), FoodChain ID Group, Inc (U.S.), AsureQuality (New Zealand), Campden BRI (U.K.), ANGLE plc (U.K.)
Pathogen detection is critical in disease diagnosis. When patients exhibit symptoms suggestive of a pathogenic infection, blood, urine, saliva, and stool samples are collected and subjected to pathogenic detection assays for diagnostic purposes. The most common pathogen detection tools are polymerase chain reaction (PCR), culture and colony counting methods, and immunology-based methods. They involve DNA analysis, bacterial counting, and antigen-antibody interactions.
Pathogen Detection Market Dynamics
- Rising genetic testing technology
Genetic testing technology is increasingly being used to detect pathogens on food in a quick, sensitive, and reliable manner. Genetic testing techniques detect pathogens even when they are newly formed or in minute concentrations. For instance, in 2019, at a healthcare conference in San Francisco, California, a Biotech startup firm LexaGena announced LX2, the world's first on-site, open access pathogen detection instrumentation that can be used for food safety, veterinary diagnostics. The company is currently developing the analyzer and plans to launch it in the market.
- Increase in R&D activities
New advances in R&D have assisted in mitigating the impact of pathogen-based infectious disease burden. Furthermore, the rapid detection and accuracy of results in a shorter period of time have increased the demand for pathogen detection in the coming years. According to a Research America article published in 2017, the United States spent USD 182.3 billion on R&D activities for medical and health causes in the United States, as well as the development of innovative technology. In contrast, the industrial sector invested approximately USD 121.8 billion in medical and health research and development activities, accounting for 67% of total expenditure.
- Technological advancements
With recent advances in the speed with which primary genome sequences can be acquired and analyzed, other detection or screening formats may become more widely available, and additional regions of microbial (and viral) genomes may be targeted more frequently. For instance, high-density oligonucleotide or amplified DNA products can be used to screen complex pools of microbial nucleic acid for specific agents in a massively parallel and efficient manner. This technological platform eliminates the need to clone and sequence large numbers of variant microbial molecules, which is especially important in analyzing clinical specimens.
- High cost of identification tests
The predominant techniques currently used to identify microbial pathogens rely on well-established clinical microbiology monitoring approaches, which have several significant drawbacks. Standard culture and susceptibility tests can identify pathogens, but they are time-consuming, expensive, and require labile natural products. More importantly, the pathogen identification tests that are commonly used do not directly characterize virulence factors. These all factors hamper the growth of the market.
This pathogen detection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pathogen detection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Pathogen Detection Market Scope
The pathogen detection market is segmented on the basis of type, consistency, culture media, contaminant type, total count, food type, technology, customer type, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Solid Media
- Liquid Media
- Chemical Composition
- Synthetic Media
- E. Coli
- Clostridium Perfringens
- Spoiling Organisms
- Yeast and Moulds
- Other Molecular-Based Tests
- Service Lab
- Governmental/Non-Profit Organization
- Clinical Research
- Drug Discovery
- Pathology Laboratories
- Diagnostic Centers
- Biotechnology Companies
- Pharmaceutical Companies
- Culture Collection Repositories
- Cooling Towers
- Blood Banks
- Direct Tender
- Retail Sales
Pathogen Detection Market Regional Analysis/Insights
The pathogen detection market is analysed and market size insights and trends are provided by country, type, consistency, culture media, contaminant type, total count, food type, technology, customer type, application, end user and distribution channel as referenced above.
The countries covered in the pathogen detection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pathogen detection market because of their high investment and high demand for pathogen detection products and services solution in the U.S.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to a rise in more concern towards pathogen detection.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The pathogen detection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pathogen detection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pathogen detection market. The data is available for historic period 2011-2021.
Competitive Landscape and Pathogen Detection Market Share Analysis
The pathogen detection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pathogen detection market.
Some of the major players operating in the pathogen detection market are:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- BIOMÉRIEUX (France)
- Agilent Technologies, Inc. (U.S.)
- BD (U.S.)
- biotools (U.S.)
- SGS Société Générale de Surveillance SA (Switzerland)
- Bureau Veritas (India) Private Limited (India)
- Intertek Group plc (U.K.)
- Eurofins Scientific (Luxembourg)
- Mérieux NutriSciences Corporation (France)
- ifp Institut für Produktqualität GmbH (Germany)
- ALS (Australia)
- Microbac Laboratories, Inc. (U.S.)
- FoodChain ID Group, Inc (U.S.)
- AsureQuality (New Zealand)
- Campden BRI (U.K.)
- ANGLE plc (U.K.)